Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:NAD)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST003252 AN005328 Metabolomics studies on mouse cardiac samples on a Western diet Heart Mouse Obesity; Diabetes; Hypertension; Hyperglycemia University of Sydney abundance
ST003252 AN005329 Metabolomics studies on mouse cardiac samples on a Western diet Heart Mouse Obesity; Diabetes; Hypertension; Hyperglycemia University of Sydney abundance
ST003253 AN005331 Metabolomics studies on mouse liver samples on a Western diet Liver Mouse Obesity; Diabetes; Hypertension; Hyperglycemia University of Sydney abundance
ST003253 AN005332 Metabolomics studies on mouse liver samples on a Western diet Liver Mouse Obesity; Diabetes; Hypertension; Hyperglycemia University of Sydney abundance
ST003438 AN005651 Unbiased genetic screening and metabolomics identifies glial adenosine metabolism as a therapeutic target in Parkinson’s disease Fly Head Fly Parkinson's Disease Broad Institute of MIT and Harvard Abundances
ST003199 AN005249 Metabolite profiling in the liver from fasted eIF4ES209A (S209A) mice compared to fasted wild type (WT) mice Liver Mouse Cancer University of Chicago A.U.
ST003365 AN005514 Intracellular and medium metabolomics for BT-474 breast cancer cells treated with a range of Fasnall and GSK2194069 concentrations for 24 h Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003365 AN005515 Intracellular and medium metabolomics for BT-474 breast cancer cells treated with a range of Fasnall and GSK2194069 concentrations for 24 h Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003366 AN005516 Malate dehydrogenase (MDH) inhibition assay: Fasnall does not affect MDH activity in vitro Synthetic Other Cancer Wistar Institute Counts per second (cps)
ST003366 AN005517 Malate dehydrogenase (MDH) inhibition assay: Fasnall does not affect MDH activity in vitro Synthetic Other Cancer Wistar Institute Counts per second (cps)
ST003367 AN005518 Intracellular and medium metabolomics for BT-474 cells treated with a range of C75 concentrations for 24 h Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003367 AN005519 Intracellular and medium metabolomics for BT-474 cells treated with a range of C75 concentrations for 24 h Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003411 AN005602 Intracellular and medium metabolomics for BT-474 cells treated with a range of C75 concentrations for 24 h (C75 MRM included) Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003411 AN005603 Intracellular and medium metabolomics for BT-474 cells treated with a range of C75 concentrations for 24 h (C75 MRM included) Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003412 AN005604 Intracellular and medium metabolomics for BT-474 cells treated with cerulenin, TVB-2640, and TVB-3166 for 24 h Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003412 AN005605 Intracellular and medium metabolomics for BT-474 cells treated with cerulenin, TVB-2640, and TVB-3166 for 24 h Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003427 AN005627 Intracellular and medium metabolomics of BT-474 cells treated with dimethylmalonate Breast cancer cells Human Cancer Wistar Institute Counts per second (cps)
ST003427 AN005628 Intracellular and medium metabolomics of BT-474 cells treated with dimethylmalonate Breast cancer cells Human Cancer Wistar Institute Counts per second (cps)
ST003428 AN005629 Intracellular and medium metabolomics of BT-474 cells treated with rotenone Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003428 AN005630 Intracellular and medium metabolomics of BT-474 cells treated with rotenone Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003429 AN005631 Intracellular and medium metabolomics of BT-474 cells treated with Fasnall that was manufactured by Enamine Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003429 AN005632 Intracellular and medium metabolomics of BT-474 cells treated with Fasnall that was manufactured by Enamine Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003430 AN005633 Intracellular and medium metabolomics of BT-474 cells treated with GSK2194069 Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003430 AN005634 Intracellular and medium metabolomics of BT-474 cells treated with GSK2194069 Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003431 AN005635 Metabolomics analysis of breast cancer cell lines treated with dimethylmalonate (DMM), GSK2194069, and their combination. Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003431 AN005636 Metabolomics analysis of breast cancer cell lines treated with dimethylmalonate (DMM), GSK2194069, and their combination. Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003432 AN005637 Intracellular and medium metabolomics of BT-474 cells treated with LW6 Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003432 AN005638 Intracellular and medium metabolomics of BT-474 cells treated with LW6 Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003433 AN005639 Intracellular and medium metabolomics of BT-474 cells treated with dimethylmalonate, Fasnall, and GSK2194069 Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003433 AN005640 Intracellular and medium metabolomics of BT-474 cells treated with dimethylmalonate, Fasnall, and GSK2194069 Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003434 AN005641 Plasma concentrations of Fasnall in mice after a bolus of 10 mg/kg administered intraperitoneally. Blood Human Cancer Wistar Institute Counts per second (cps)
ST003434 AN005642 Plasma concentrations of Fasnall in mice after a bolus of 10 mg/kg administered intraperitoneally. Blood Human Cancer Wistar Institute Counts per second (cps)
ST003435 AN005643 Metabolomics analysis of zebrafish embryos treated with rotenone, Fasnall, TVB-2640, and GSK2194069 Media, Metabolite extract Zebra fish Cancer Wistar Institute Counts per second (cps)
ST003435 AN005644 Metabolomics analysis of zebrafish embryos treated with rotenone, Fasnall, TVB-2640, and GSK2194069 Media, Metabolite extract Zebra fish Cancer Wistar Institute Counts per second (cps)
ST003436 AN005645 Pharmacokinetics of Fasnall in NSG mice Brain, Heart, Liver, Blood Mouse Cancer Wistar Institute Counts per second (cps)
ST003436 AN005646 Pharmacokinetics of Fasnall in NSG mice Brain, Heart, Liver, Blood Mouse Cancer Wistar Institute Counts per second (cps)
ST003323 AN005439 Global Metabolomics and U-13C6-Glucose Tracing in Bone Marrow Derived Macrophages (BMDM) Bone marrow Mouse Immune system disorders University of Colorado Anschutz Medical Campus Intensity Counts
ST003454 AN005675 Branched chain alpha-ketoacids impact pulmonary artery smooth muscle cell metabolism Cultured cells Human Hypertension Peking University ion intensity
ST003455 AN005676 Metabolic alterations in pulmonary artery smooth muscle cells of idiopathic pulmonary arterial hypertension (IPAH) patients. Cultured cells Human Hypertension Peking University ion intensity
ST003405 AN005588 Specific activation of the integrated stress response uncovers regulation of central carbon metabolism and lipid droplet biogenesis Cultured cells Human Cancer Calico Life Sciences log2 peak area top
ST003405 AN005589 Specific activation of the integrated stress response uncovers regulation of central carbon metabolism and lipid droplet biogenesis Cultured cells Human Cancer Calico Life Sciences log2 peak area top
ST003331 AN005457 Increased Cholesterol Synthesis Drives Neurotoxicity in Patient Stem Cell-Derived Model of Multiple Sclerosis - cellular metabolomics Stem cells Human Multiple sclerosis University of Colorado Denver peak area
ST003347 AN005482 ADSL deficiency drives mitochondrial dysfunction and ERK2 dysregulation in a linear genotype to phenotype correlation Skin Human Neuropathy Catholic University of the Sacred Heart peak area
ST003484 AN005722 Metabolism of TNBC cell line MDA-MB-453 is altered by cytokines, TDO2 inhibition, or suspension growth conditions - cellular steady state metabolome and in vitro tracing with 13C11 tryptophan Tumor cells Human Cancer University of Colorado Anschutz Medical Campus peak area
ST003249 AN005322 Mitochondrial respiration impairment in microglia dampens response to demyelinating injury but is not sufficient to induce an aging phenotype Microglia Mouse Alzheimers disease Northwestern University Peak area
ST003265 AN005349 Malic Enzyme 2 maintains metabolic state and anti-tumor immunity of CD8+ T cells T-cells Mouse Cancer Peking Union Medical College Peak area
ST003313 AN005425 Integrative analysis of serum and fecal metabolome and the microbiome that herald Crohn Disease flare - feces Feces Human Inflammatory bowel disease; Crohn disease Sheba hospital percentage of metabolites per sample
ST003495 AN005735 Hepatocyte Period 1 dictates oxidative substrate selection independent of the core circadian clock Liver Mouse Washington University in St. Louis Raw Area
ST003389 AN005558 Disruption of Glucose Homeostasis by Bacterial Infection Orchestrates Host Innate Immunity Through NAD+/NADH Balance Macrophage Mouse Bacterial infection Northwest A&F University umol/g
ST003389 AN005557 Disruption of Glucose Homeostasis by Bacterial Infection Orchestrates Host Innate Immunity Through NAD+/NADH Balance Macrophage Mouse Bacterial infection Northwest A&F University μmol/g
ST003267 AN005353 FDX2-KO induces global down-regulation of iron-sulfur cluster-containing proteins and senescence-like growth arrest or death in ovarian cancer cells Cultured cells Human Cancer Tohoku University μmol/g-protein
  logo